According to a recent LinkedIn post from Draig Therapeutics, CEO and President Ivana Magovcevic-Liebisch is scheduled to participate in an off-the-record C-suite session at the upcoming Convergence Forum. The session, set for Friday, May 8 from 10:15 to 11:15 a.m., will include senior leaders from Aitia, Xilio Therapeutics, Inc., and Atlas Venture.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Draig Therapeutics is positioning its leadership alongside prominent industry and investment figures to discuss key healthcare topics in a closed-door setting. For investors, this type of participation may signal efforts to strengthen strategic relationships, gain industry insights, and potentially access future partnering or financing opportunities, although no specific business outcomes are indicated in the post.